Topoisomerase II Alpha
Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a / mutants
18
<p>3,6-Disubstituted 1,2,4-Triazolo[3,4-<em>b</em>]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha</p>
18
Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer
10
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2 positive metastatic breast cancer treated with trastuzumab
13
The significance of Epstein Barr Virus (EBV) & DNA Topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, Oral Epithelial Dysplasia (OED) and Oral Squamous Cell Carcinoma (OSCC)
13
P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
9
Protein interactions at the human topoisomerase II[alpha] promoter : a thesis presented to Massey University in partial fulfilment of the requirement for the degree Doctor of Philosophy in Biochemistry
188
QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
13
A role for topoisomerase II alpha in chromosome damage in human cell lines
180
Analysis in Carcinoma Stomach Her-2/neu Positivity by Immuno-histochemistry
122
Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
15
Hypersensitive Inhibition of the Proliferation of Cells with Mutated DNA Repair Related Genes by the Catalytic Topoisomerase II Inhibitor 20 O IngenolEZ
8
The ATP dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning
12
In silico identification and evaluation of hits for the inhibition of topoisomerase-ii enzyme via structure based pharmacophore mapping and virtual screening
8
Contribution of Immunohistochemistry in Prognostic Assessment of Epithelial Ovarian Carcinoma – Review of the Literature I.
5
cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
14
Genetic analysis of the gyrase A-like domain of DNA topoisomerase II of Saccharomyces cerevisiae.
14
SIZ1/SIZ2 Control of Chromosome Transmission Fidelity Is Mediated by the Sumoylation of Topoisomerase II
12
Assessment of drug induced genotoxicity in mammalian cells and the contribution of topoisomerase II inhibition
250
A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia
8